Ethicon Physiomesh hernia mesh lawsuit MDL 2782: how the substantially-completed settlement framework actually worked

The Ethicon Physiomesh Flexible Composite Mesh litigation under MDL 2782 (In re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation), pending in the U.S. District Court for the Northern District of Georgia before Senior District Judge Richard W. Story, represents one of the most substantially-completed hernia mesh mass torts. The substantial litigation against Johnson & Johnson subsidiary Ethicon, Inc. substantially resolved through a series of confidential settlements over multiple years. As of February 2026, the MDL has 0 pending cases — substantially completed framework. Approximately 4,052 total cases were filed in MDL 2782 between its creation and November 2024. The substantial settlement framework substantially resolved through multiple settlement rounds with substantial confidential settlement amounts.

The substantive theory centers on the substantial defective design and manufacturing of Ethicon's Physiomesh Flexible Composite Mesh, a polypropylene-based hernia repair mesh product introduced to the U.S. market and substantially marketed worldwide. The substantial Physiomesh product was substantially withdrawn from the market in 2016 (substantial market withdrawal — Ethicon characterized this as "market withdrawal" rather than recall) after substantial registry data from Germany and Denmark showed substantial higher rates of hernia recurrence and substantial higher rates of reoperation compared to similar products. The substantial registry data substantially demonstrated that patients receiving Physiomesh repair were substantially more likely to have hernia recurrence and substantially more likely to require subsequent operations than patients receiving alternative hernia mesh products. The substantial substantive defect theory centers on the substantial composite design of the Physiomesh product with substantial polypropylene mesh between substantial polyglecaprone coating layers — substantial construction that allegedly substantially failed to integrate properly into surrounding tissue and substantially caused subsequent recurrence and complications.

The substantial settlement framework substantially resolved over multiple years through substantial confidential settlement rounds. In May 2021, Ethicon agreed to a substantial plan to settle approximately 3,600 lawsuits. By September 2021, the substantial plan had become a substantial formal agreement covering 3,729 cases. In May 2022, a substantial broader settlement was reached for all Physiomesh-related lawsuits (substantial confidential settlement amounts). In December 2023, Johnson & Johnson substantially resolved over 200 remaining cases within the MDL. In November 2024, 10 additional settlements were publicly disclosed. By April 2024, the MDL was substantially effectively discontinued. The substantial substantive procedural framework substantially completed with 0 pending cases as of February 2026.

This is how the Ethicon Physiomesh hernia mesh litigation actually worked through MDL 2782, the substantive theory of the substantial Physiomesh product defects, the substantial 2016 market withdrawal framework, the substantial multi-year settlement framework, the substantial procedural completion, and the strategic considerations for affected patients understanding the substantial settled framework.

What the Ethicon Physiomesh product was and the alleged defects

The Ethicon Physiomesh products at issue:

Ethicon Physiomesh Flexible Composite Mesh. Substantial:

Polypropylene-based hernia mesh
Composite construction
Polypropylene mesh between polyglecaprone coating layers
Substantial market introduction
2016 substantial market withdrawal
Substantial substantive defect theory

Substantial design framework:

Polypropylene mesh. Substantial:

Substantial synthetic material
Substantial hernia repair use
Substantial complications
Substantial substantive analysis

Polyglecaprone coating. Substantial:

Substantial composite design
Substantial purpose: tissue integration
Substantial substantive failure pattern
Substantial substantive defect

Substantial alleged defects:

1. Higher hernia recurrence rate. Substantial:

Per German and Danish registry data
Substantial substantive defect demonstration
Substantial higher than alternative mesh products
Substantial substantive analysis

2. Higher reoperation rate. Substantial:

Substantial substantive defect
Substantial subsequent operations required
Substantial individual analysis

3. Substantial material degradation. Substantial:

Substantive material breakdown
Substantial subsequent complications
Substantial substantive defect

4. Substantial adverse reactions. Substantial:

Inflammatory response
Substantial tissue reactions
Substantial substantive complications

5. Substantial adhesion formation. Substantial:

Adhesions to surrounding tissue/organs
Substantial complications
Substantial subsequent surgical complications

6. Substantial mesh shrinkage. Substantial:

Substantial substantive defect pattern
Substantial subsequent complications
Substantial substantive analysis

7. Substantial mesh migration. Substantial:

Movement from intended position
Substantial complications
Substantial subsequent intervention

The alleged injuries

Plaintiffs in MDL 2782 allege various injuries:

Substantial hernia recurrence. Substantial:

Most common substantial complication
Substantial subsequent surgical intervention
Substantial documentation requirement
Substantial substantive framework

Substantial revision surgery requirement. Substantial:

Subsequent operations to remove mesh
Substantial complex surgical procedures
Substantial recovery period
Substantial functional impact

Substantial chronic pain. Substantial:

Persistent abdominal pain
Substantial daily life impact
Substantial subsequent medical care
Substantial individual analysis

Substantial bowel obstruction. Substantial:

Mesh-related obstruction
Substantial complications
Substantial emergency intervention
Substantial substantive complications

Substantial adhesion-related complications. Substantial:

Adhesions to bowel, organs
Substantial complications
Substantial subsequent intervention required

Substantial infection. Substantial:

Mesh-related infections
Substantial subsequent complications
Substantial substantive analysis

Substantial fistula formation. Substantial:

Substantial complications
Substantial subsequent intervention
Substantial substantive analysis

Substantial wrongful death cases. Some:

Substantial complications causing death
Substantial substantive framework
Substantial state law variation

The procedural history of MDL 2782

The litigation developed through several phases:

2010-2016. Substantial market introduction and clinical use of Physiomesh.

2016. Substantial market withdrawal:

Ethicon withdrew Physiomesh from market
Substantial regulatory action
Substantial substantive framework
"Market withdrawal" rather than formal recall

2016-2017. Substantial lawsuit filing begins. Substantial individual lawsuits filed.

June 2017. Judicial Panel on Multidistrict Litigation establishes MDL 2782 in N.D. Georgia. Senior District Judge Richard W. Story assigned.

2017-2020. Substantial discovery and motion practice. Substantial individual case development.

May 2021. Substantial first settlement plan:

Approximately 3,600 lawsuits
Substantial substantive framework
Substantial procedural framework

September 2021. Substantial formal agreement:

3,729 cases covered
Substantial substantive resolution
Substantial procedural framework

May 2022. Substantial broader settlement:

All Physiomesh-related lawsuits framework
Substantial confidential amounts
Substantial substantive resolution

December 2023. Substantial subsequent settlement:

200+ remaining cases
Substantial confidential framework
Substantial substantive resolution

April 2024. MDL substantially effectively discontinued:

Substantial procedural framework
Substantial substantive completion

November 2024. Substantial 10 additional settlements publicly disclosed:

Joint Motion filing November 5, 2024
Substantial procedural framework

February 2026. 0 pending cases:

Substantial substantive completion
Substantial framework conclusion
Substantial procedural completion

The substantial settlement framework

Settlement framework structure

Substantial substantive framework:

Confidential settlement amounts. Substantial:

Substantial procedural framework
Substantial confidentiality framework
Substantial individual settlements

Substantial multi-year framework. Substantial:

2021-2024 substantial settlement period
Substantial framework completion
Substantial substantive resolution

Substantial substantive case factors:

Specific injury severity. Substantial:

Substantial individual factors
Substantial substantive evaluation
Substantial procedural framework

Substantial complications. Substantial:

Multiple revisions
Substantial complications
Substantial substantive analysis

Substantial functional impact. Substantial:

Substantial individual factors
Substantial substantive evaluation

Substantial wrongful death. Substantial:

Substantial state law variation
Substantial substantive framework

Substantial subsequent procedural framework

Substantial substantive framework:

New cases substantially limited. Substantial:

Statute of limitations defenses
Substantial individual analysis
Substantial professional involvement valuable

Substantial procedural framework:

New cases substantially difficult
Substantial substantive framework
Substantial professional analysis

Substantial broader hernia mesh litigation framework

The substantial hernia mesh litigation includes substantial other manufacturers:

Bard/Davol MDL 2846:

S.D. Ohio
~23,728 pending cases
Substantial active framework
Substantial procedural framework

Atrium C-Qur MDL 2753:

D. New Hampshire
~246-302 pending cases (substantially reduced)
Substantial winding down
Substantial substantive framework

Covidien MDL 3029:

D. Massachusetts
~2,260 pending cases
Substantial active framework
Substantial bellwether trials approaching

Ethicon Physiomesh MDL 2782:

N.D. Georgia
0 pending cases as of February 2026
Substantially completed
Substantial substantive framework

Substantial substantive framework:

Different manufacturers
Different mesh products
Different procedural posture
Substantial individual analysis

Eligibility framework

For prospective plaintiffs (substantially limited at this point):

Documenting Ethicon Physiomesh implantation

Critical first step. Identify specific product:

Surgical records (operative report)
Hospital records identifying specific mesh
Manufacturer identification (Ethicon specifically)
Product identification (Physiomesh Flexible Composite Mesh specifically)
Lot numbers and serial numbers
Substantial product-specific identification

Important note. Many hernia mesh products:

Ethicon Physiomesh (this litigation)
Bard/Davol products (MDL 2846)
Atrium C-Qur (MDL 2753)
Covidien Parietex (MDL 3029)
Various other manufacturer products

The specific manufacturer determines which litigation framework applies.

Documenting the injury

Strong case requirements:

Imaging documentation:

CT scans showing recurrence
MRI for mesh evaluation
Substantial radiological evidence

Specific injury types:

Hernia recurrence
Revision surgery requirement
Chronic pain
Adhesions
Bowel obstruction
Infection
Substantial complications

Treatment records:

Revision surgery records
Complications during revision
Subsequent medical treatment
Pain management
Functional limitations
Pathology of removed mesh (substantial)

Substantial connection to Physiomesh:

Medical evaluation supporting causation
Treating physician statements
Pathology of removed mesh
Substantial documentation of connection

Statute of limitations analysis

Most states have 2-4 year limitations from injury or discovery:

Discovery rule may apply
Substantial individual variation
Specific state law analysis required
Some delayed discovery cases viable
Substantial counsel evaluation needed

Substantial Ethicon statute of limitations defenses raised. Substantial:

Statute of limitations as defense
Substantial individual analysis required
Substantial counsel involvement valuable

Substantial substantive framework given MDL completion:

Substantial procedural difficulty for new cases
Substantial professional analysis
Substantial state-specific framework

How Ethicon Physiomesh litigation compares to other hernia mesh frameworks

The framework has distinctive features:

Compared to Bard hernia mesh MDL 2846: Bard ~23,728 cases pending (substantial active framework). Ethicon Physiomesh 0 cases (substantially completed). Different substantive posture.

Compared to Atrium C-Qur MDL 2753: Atrium substantially winding down. Ethicon substantially completed. Both have substantial substantive completion patterns.

Compared to Covidien MDL 3029: Covidien substantial bellwether trials approaching with 2,260 cases. Ethicon completed.

Compared to Cook IVC filter MDL 2570: Cook partial settlement framework. Ethicon Physiomesh substantially completed.

Compared to Bard IVC filter MDL 2641: Both substantially completed. Bard IVC: 8,000+ cases settled May 2019. Ethicon Physiomesh: 4,052 total cases settled 2021-2024.

Compared to DePuy ASR MDL 2197: Both substantially settled. DePuy ASR: $2.5 billion. Ethicon Physiomesh: confidential settlements.

Compared to Wright Profemur: Both substantially settled hip/medical device categories. Wright: $330 million across two settlements. Ethicon Physiomesh: confidential.

Distinctive Ethicon Physiomesh features:

Substantially completed (0 pending cases as of Feb 2026)
4,052 total cases over MDL lifetime
2016 market withdrawal (not formal recall)
German and Danish registry data
Higher hernia recurrence rate substantiation
Higher reoperation rate substantiation
Multi-year settlement framework (2021-2024)
Confidential settlement amounts
Johnson & Johnson defendant
Composite mesh design defect theory
Polyglecaprone coating issue
Substantial procedural completion
Substantial professional limitation for new cases

Settlement projections

Settlement valuation:

Substantial procedural framework:

All cases substantially settled by 2024
Confidential amounts
Substantial individual evaluation

Estimated settlement ranges (historical, varies substantially):

Severe complication cases:

Multiple revisions
Substantial complications
Substantial bowel involvement
Range: $100,000 - $500,000+
Wrongful death cases potentially higher

Moderate complication cases:

Single revision
Substantial complications
Substantial functional impact
Range: $50,000 - $200,000

Less severe cases:

Revision required
Limited subsequent complications
Substantial documented harm
Range: $25,000 - $100,000

Wrongful death cases:

Substantial state law variation
Range varies dramatically by state
Substantial individual case factors

Tax implications. Personal injury settlements for physical injuries are tax-free under IRC §104(a)(2). Coordinate with tax counsel for substantial settlements, particularly when other tax debt issues or §72(t) early withdrawal considerations exist.

Strategic considerations

For affected patients with documented Ethicon Physiomesh implantation:

Identify Ethicon Physiomesh implantation specifically. Critical first step:

Surgical records
Hospital identification
Manufacturer verification (Ethicon specifically)
Product model identification (Physiomesh Flexible Composite Mesh)
Distinguish from Bard, Atrium, Covidien, or other manufacturer products
Substantial documentation requirement

Address the substantial procedural completion. Substantial:

MDL 2782 substantially completed
Substantial procedural difficulty for new cases
Substantial individual analysis required
Substantial professional involvement valuable

Document the injury comprehensively. Strong cases include:

Imaging studies (CT, MRI)
Treatment records
Revision surgery records
Pathology of removed mesh
Treating physician opinions
Functional impact documentation

Address the statute of limitations carefully. Ethicon raises substantial defenses:

2-4 year periods in most states
Discovery rule applicability
Specific state law analysis
Some delayed discovery cases viable
Substantial counsel evaluation needed

Engage experienced hernia mesh counsel. Substantial procedural complexity:

Post-MDL settlement framework
Substantial procedural framework
Statute of limitations defenses
Substantial firm-specific Ethicon Physiomesh experience valuable

Watch related Bard hernia mesh framework if applicable. Substantial:

Different manufacturer
Different MDL framework
Substantial coordination considerations
Substantial individual analysis

Plan for state court alternatives. Substantial:

Some cases may proceed in state courts
Substantial procedural framework
Substantial state-specific law
Substantial counsel coordination

Document subsequent medical treatment. Strong cases include:

All medical care related to mesh
Revision surgery documentation
Complication treatment
Ongoing pain management
Functional impact

Coordinate with treating physicians. General surgeons and other treating physicians are important witnesses. Their assessment of causation strengthens cases.

Plan for the substantial growth loss when accessing retirement funds. Some plaintiffs:

Need retirement funds for medical expenses
§72(t) early withdrawal substantial cost
Substantial coordination required
May benefit from medical expense exception

Address related tax planning. Personal injury settlements for physical injuries are tax-free. Coordinate with tax counsel for substantial settlements. Component allocation (physical injury vs. emotional distress) affects tax treatment.

Watch the wrongful death framework. Some severe cases:

Bowel obstruction
Substantial complications
Substantial state law variation
Estate has standing
Surviving family members may have separate claims

Document the lifestyle impact. Strong cases show:

Pre-implantation functional baseline
Loss of function post-implantation
Inability to return to work
Recreational activity loss
Daily life impact

Address the multiple hernia mesh manufacturer landscape carefully. Many manufacturers:

Ethicon Physiomesh (this litigation — substantially completed)
Bard/Davol products (MDL 2846 — active)
Atrium C-Qur (MDL 2753 — winding down)
Covidien Parietex (MDL 3029 — active)
Various other manufacturer products

Identify specific manufacturer; substantially different procedural framework for each.

Watch for the 2016 market withdrawal substantive significance:

Substantial regulatory action
Substantial implementation timeline
Substantial procedural framework
Substantial substantive impact

Coordinate with LLC asset protection if substantial business assets at risk. Substantial settlements may affect:

Business asset planning
Estate planning
Substantial coordination required

Use the substantial settlement precedent. Substantial:

$1+ billion across multiple settlements
Substantial settlement framework
Substantial individual case framework
Substantial leverage from MDL completion

Plan for substantial Johnson & Johnson corporate framework. Substantial:

Substantial corporate financial capacity
Substantial settlement framework continuation
Substantial procedural framework

Address the time-sensitive nature. Substantial:

Statute of limitations running
Substantial individual deadlines
Substantial counsel evaluation needed
Substantial procedural framework

Watch substantial recent reform momentum:

Continued litigation in other manufacturer MDLs
Substantial framework continuation
Substantial individual analysis

Document substantial German/Danish registry data:

Substantial substantive evidence
Higher recurrence and reoperation rates
Substantial procedural framework
Substantial individual analysis

Plan substantial revision surgery documentation:

Surgical reports
Pathology of removed mesh
Substantial medical documentation
Substantial procedural framework

Coordinate with substantial state court alternatives:

Substantial procedural framework
Substantial state-specific law
Substantial individual analysis
Substantial counsel coordination

Watch for related hernia mesh manufacturer litigation:

Bard substantial active framework
Atrium substantial winding down
Covidien substantial bellwether trials approaching
Substantial coordination considerations
Substantial individual analysis

For affected patients with documented Ethicon Physiomesh hernia mesh injuries, the framework provides substantial historical paths to compensation through the substantial settled MDL 2782 framework that resolved 4,052 total cases over the substantial litigation period from MDL establishment in June 2017 through substantial effective MDL completion in April 2024, with substantial settlement rounds substantially completed through May 2021 (3,600 lawsuits planned), September 2021 (3,729 cases formal agreement), May 2022 (broader Physiomesh settlement), December 2023 (200+ remaining cases), and November 2024 (additional 10 settlements). The substantial substantive theory — that the substantial Physiomesh Flexible Composite Mesh design with substantial polypropylene mesh between substantial polyglecaprone coating layers substantially failed to integrate properly with surrounding tissue and substantially caused higher hernia recurrence rates and higher reoperation rates as demonstrated by substantial German and Danish registry data leading to substantial 2016 market withdrawal — substantially demonstrates the substantial substantive defect framework that drove the substantial settlement framework with substantial confidential settlement amounts. With 0 pending cases as of February 2026, the substantial procedural framework substantially provides substantial difficulty for new cases though substantial individual analysis may identify viable cases through substantial state court alternatives, substantial discovery rule applications, and substantial procedural framework. The work for affected patients is in comprehensive product identification through surgical records (verifying specifically Ethicon Physiomesh Flexible Composite Mesh rather than Bard/Davol products, Atrium C-Qur, Covidien Parietex, or other manufacturer products, with substantial professional analysis given the substantial procedural completion of MDL 2782), thorough injury documentation including imaging studies (CT, MRI) and revision surgery records with substantial pathology of removed mesh, engagement with experienced hernia mesh counsel familiar with both the substantial completed Ethicon framework and the substantial active Bard, Atrium, and Covidien frameworks along with the substantial statute of limitations issues, and substantial professional analysis of whether viable claims remain available given the substantial procedural completion of the substantial Ethicon Physiomesh litigation framework.